MSF Malaria Project in Cambodia
Read: All MSF updates on COVID-19
Read more
Our projects in Cambodia are currently focused on tackling hepatitis C and malaria.

We launched a hepatitis C programme in Cambodia in May 2016, offering the first free treatment for the blood-borne virus in the country. Although the prevalence of the disease is unknown, it is estimated that between 2 and 5 per cent of the population is infected.

The team started by screening HIV patients at the hospital for co-infection; today teams have expanded screening to include patients referred by Preah Kossamak hospital’s hepatology department.

Our malaria research project in northern Cambodia was set up to find ways to eliminate malaria in an area where there is proven resistance to the most powerful antimalarial drug, artemisinin.

MSF teams responded to the coronavirus COVID-19 pandemic in the country between February and June 2020, in which training and technical support was provided in six hospitals.

In 2018
 
Journal article

Plasmodium prevalence and artemisinin-resistant falciparum malaria in Preah Vihear Province, Cambodia: a cross-sectional population-based study

27 Oct 2014
Journal article
 
Cambodia Active Case Finding Pilot Program
Cambodia

Cambodia wasn’t initially on Helen Tindall’s radar ...

Voices from the Field 4 Jul 2014
 
Journal article

Spatial epidemiology and climatic predictors of paediatric dengue infections captured via sentinel site surveillance, Phnom Penh Cambodia 2011-2012

28 Jun 2014
Journal article
 
Cambodia Active Case Finding Pilot Program
Tuberculosis

Active Case Finding in Cambodia: Searching for TB one village at a time

Project Update 14 Apr 2014
 
Journal article

Plasma Concentrations, Efficacy and Safety of Efavirenz in HIV-Infected Adults Treated for Tuberculosis in Cambodia

7 Mar 2014
Journal article
 
Cambodia

Improving TB detection and treatment in prisons

Project Update 20 Mar 2012